PepLabo Download

Heartburn and indigestion on Ozempic®

Heartburn, indigestion and reflux on Ozempic: the smaller rates under the main US table, the EU and Canadian figures, a 2025 meta-analysis and what helps.

Published · Updated · Ozempic®: side effects by symptom · Written by the PepLabo editorial team

When to get help
Context and scope

Heartburn and indigestion do not make it into the main side-effect table of the Ozempic® label, but they are not missing either. They sit in a sentence just below it, and the European and Canadian product information list them more plainly. This page puts those numbers side by side, adds what a 2025 meta-analysis found about reflux, and gathers public health advice on what helps and which chest or stomach symptoms need urgent attention.

Key takeaways 4
  • In Canada’s seven-trial pool, reflux disease was reported by 1.6% on 0.5 mg and 2.7% on 1 mg, against 1.0% on comparators [3].
  • When semaglutide 1 mg was added to an SGLT2 inhibitor, reflux disease affected 4% on semaglutide and no one on placebo, and did not fade over time [2].
  • A 2025 meta-analysis of 55 placebo-controlled trials found GLP-1 medicines probably increase reflux disease, by about 4 extra cases per 1,000 people [4].
  • MedlinePlus warns that chest burning with squeezing or pressure can be a heart attack rather than heartburn [5].

Why these reactions are easy to miss

Table 1 of the US Ozempic® label only includes reactions reported by at least 5% of treated adults. Everything less frequent but still associated with the medicine appears in running text underneath, using medical terms: dyspepsia for indigestion, gastroesophageal reflux disease (GERD) for acid coming back up, eructation for burping and gastritis for inflammation of the stomach lining. The numbers come from the same two placebo-controlled trials in adults with type 2 diabetes as the main table [1].

Europe takes a different route and places dyspepsia, gastritis, reflux disease, eructation, flatulence and abdominal distension together in its common class, between 1 in 100 and 1 in 10 people [2].

The upper-stomach rates in two documents

The US figures compare Ozempic® with placebo; the Canadian figures come from a larger seven-trial pool with a comparator group that mixes placebo and other diabetes medicines [1][3].

Upper-stomach reactions with Ozempic®: US (placebo) and Canadian (comparator) pools
ReactionUS: placebo / 0.5 mg / 1 mg [1]Canada: comparator / 0.5 mg / 1 mg [3]
Dyspepsia (indigestion)1.9% / 3.5% / 2.7%2.1% / 4.1% / 5.2%
Gastroesophageal reflux disease0% / 1.9% / 1.5%1.0% / 1.6% / 2.7%
Eructation (burping)0% / 2.7% / 1.1%0.2% / 1.3% / 1.8%
Gastritis0.8% / 0.8% / 0.4%0.5% / 1.6% / 1.2%
Abdominal distension (bloating)Not listed0.8% / 2.3% / 2.9%

What the pattern suggests

In the US table, reflux and burping were not reported at all on placebo, and indigestion was more frequent on both doses than on placebo. Gastritis on Ozempic® was no higher than on placebo. In each upper-stomach row the 0.5 mg group reported slightly more than the 1 mg group, which the label does not explain [1].

The Canadian pool, which is about six times larger, runs the other way for indigestion, reflux and burping: the 1 mg group reported a little more than the 0.5 mg group [3]. With small numbers like these, the safest reading is that both doses sit above the comparison group and the order between doses is not settled.

Timing is less clear than for nausea. The US label ties nausea, vomiting and diarrhea to dose escalation but says nothing similar about heartburn, and the European note on SUSTAIN 9 suggests reflux disease can persist rather than fade [1][2].

What a large meta-analysis found

A 2025 systematic review pooled 55 placebo-controlled randomised trials of GLP-1 medicines with 106,395 participants, including people with type 2 diabetes, obesity and fatty liver disease. GLP-1 medicines probably increased reflux disease (risk ratio 2.19, about 4 more cases per 1,000 people) but probably had little or no effect on gastritis, oesophagitis or stomach ulcers [4].

The rise in reflux looked larger in trials of people with overweight or obesity, of medicines that cause more weight loss and of higher doses, although those subgroup differences were not statistically significant. The review covered the whole class, not Ozempic® alone [4].

Why it may happen

What the label supports: semaglutide causes a minor delay in stomach emptying in the early period after a meal, and Europe lists delayed gastric emptying as an uncommon reaction [1][2].

What is plausible but unproven: food staying longer in the stomach could make it easier for contents to press back up into the oesophagus. None of the Ozempic® documents states that link, and the meta-analysis measured how often reflux occurred, not why [4].

General background: MedlinePlus explains that reflux happens when the ring of muscle at the lower end of the oesophagus does not close fully, and that lying down soon after a meal, obesity, pregnancy, smoking and a hiatal hernia all make it more likely [6].

Other causes of heartburn

  • Medicines including some blood pressure and heart medicines (beta-blockers, calcium channel blockers), asthma inhalers that widen the airways, theophylline, tricyclic antidepressants, sedatives and progestin [5][6].
  • Trigger foods and drinks: alcohol, caffeine, fizzy drinks, chocolate, citrus, mint, tomatoes and spicy or fatty foods [5].
  • A hiatal hernia, pregnancy and smoking [5][6].
  • Pain that feels like heartburn but comes from the heart, the gallbladder or the pancreas; the Ozempic® label has warnings for the last two [1][5].

What may help

The Ozempic® documents give no specific advice for heartburn. The steps below come from MedlinePlus and NIDDK’s general guidance on reflux [5][7][8].

  • Eat smaller meals, and avoid bending over or exercising straight after eating [5].
  • Leave a gap of a few hours between your last meal and lying down or going to bed [5][8].
  • Raise the head end of the bed; MedlinePlus suggests blocks or a wedge under the mattress, because loose pillows tend to slip in the night [5].
  • Notice which foods seem to trigger symptoms and discuss cutting back on them with your doctor [8].
  • Avoid tight belts or waistbands, and stop smoking if you smoke [5][7].
  • Antacids and acid-reducing medicines are sold without a prescription, but NIDDK advises against daily antacid use or use for severe symptoms without talking to a doctor [7]. The Ozempic® label also asks you to tell your provider about every medicine you take, including over-the-counter ones [1].

Details worth noting

It helps to note when the burning starts relative to meals and bedtime, what you ate, whether lying down makes it worse, whether you also burp, feel bloated or bring food back up, and whether it began after starting Ozempic® or after a dose change. If you use antacids, write down how often.

Ozempic® is a registered trademark of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.

When to get help

The signs and contact information below come from this article’s sourced guidance.

Emergency

  • Burning in the chest with squeezing, crushing or pressure

    Contact: Emergency services (911); it may be a heart attack

    MedlinePlus [5]

  • Vomiting blood or material like coffee grounds, or black or maroon stools

    Contact: Urgent medical care

    MedlinePlus [5]

  • Severe stomach pain that does not ease, sometimes into the back, with or without vomiting

    Contact: Stop Ozempic® and call your healthcare provider straight away

    Medication Guide [1]

Today

  • Upper stomach pain with fever, yellow skin or eyes, or clay-coloured stools

    Contact: Your healthcare provider, straight away

    Medication Guide [1]

  • Trouble or pain swallowing, food feeling stuck, or weight loss you did not intend

    Contact: Your healthcare provider

    MedlinePlus [5][6]

At your next appointment

  • Heartburn that is frequent or does not settle after a few weeks of self-care

    Contact: Your healthcare provider or prescriber

    MedlinePlus [5]

Questions

Does Ozempic® cause heartburn?

The US label lists reflux disease in 1.9% of adults on 0.5 mg and 1.5% on 1 mg, with no cases on placebo, and indigestion in 3.5% and 2.7% against 1.9% on placebo. Europe classes both as common [1][2].

Is burping on Ozempic® in the label?

Yes. Eructation, the medical term for burping, was reported in 2.7% on 0.5 mg and 1.1% on 1 mg, and in no one on placebo, in the US trials [1].

Does Ozempic® heartburn go away?

The documents do not give a duration. Europe notes that in one trial with an SGLT2 inhibitor, reflux disease did not become less frequent over time [2]. If it persists, raise it with your prescriber.

Can I take an antacid with Ozempic®?

The label does not name a remedy, but it advises caution with medicines taken by mouth because Ozempic® slows stomach emptying, and asks you to list all your medicines, including over-the-counter ones [1]. Ask your pharmacist.

Why is heartburn not in the main Ozempic® side-effect table?

The main US table only includes reactions seen in at least 5% of treated adults. Heartburn-type reactions were less frequent, so the label lists them in the text below the table [1].

How do I tell heartburn from something more serious?

MedlinePlus says chest burning with squeezing or pressure needs emergency care because it can be a heart attack, and the Ozempic® Medication Guide lists upper stomach pain with fever or yellowing as possible gallbladder symptoms [1][5].